A 2026 study in Biochimica et Biophysica Acta - Molecular Basis of Disease reports that a small lipid molecule called 12,13-diHOME reduced fatty liver in obese mice, and it does so through a cleanup pathway the field calls lipophagy - the cell’s process of breaking down its own fat droplets. The paper is a mechanism study, not a human trial, but it is worth reading because it names a specific molecular switch - Sestrin2, AMPK, and ULK1 - that a reader can at least understand the shape of.
12,13-diHOME is a lipid produced during exercise and cold exposure, and it has been studied as a signal that increases fat burning. The new work connects it to the liver directly: in obese mice, treatment with 12,13-diHOME improved the fatty-liver picture, and the mechanism ran through Sestrin2, which activates AMPK, which switches on ULK1, which drives the lipophagy that clears fat from liver cells. That is the chain, and the study’s value is in linking all three links in one experiment.
What lipophagy has to do with a fatty liver
A fatty liver is, at the cellular level, a liver whose cells are storing more fat droplets than they are clearing. The body has a natural cleanup route for those droplets - autophagic breakdown, specifically the flavor called lipophagy - and when that route is sluggish, fat accumulates. The study frames 12,13-diHOME as a signal that turns the cleanup route back on, which is a genuinely different angle from the usual advice to simply eat less fat or sugar.
The honest boundary is the species. This is an obese-mouse study, and the jump from a mouse liver to a human kitchen is long. The value for a reader is not a supplement to buy - 12,13-diHOME is not a pantry item - but an understanding that the liver has its own fat-clearing machinery, and that some of the same signals the body makes during exercise are the ones that switch it on.
The food and movement side of the same pathway
The study’s most useful takeaway is indirect: the same AMPK and autophagic pathways that 12,13-diHOME activates are also nudged by things a person can actually do. Exercise is the natural source of exercise-linked lipids and a well-established AMPK activator, and the database has always paired food with movement for this reason. The Recommended column - vegetables, legumes, whole grains, olive oil, fatty fish - keeps the metabolic load low while the activity side keeps the cleanup machinery exercised.
The per-food numbers make the plate concrete. Rolled oats sit in Recommended at about 10 grams of fiber per 100 grams; salmon carries omega-3s at roughly 1.3 grams of saturated fat per 100 grams; olive oil and walnuts bring unsaturated fat and polyphenols. None of these is a lipophagy pill - the point is they are the pattern the liver’s own machinery responds to over time, and the mouse study is one more clue about why the pattern works.
How our editorial team read this
We treat mechanism papers with a standing rule: explain the biology, never translate it into a supplement. Our data editor verified this is a mouse study, kept the word “mice” in every claim, and did not turn a molecular switch into a product. We flagged that 12,13-diHOME is not a supplement and that no food contains it at a level a person should chase - the takeaway is the pathway, not the molecule.
What we did do is connect the study to the two levers that are real for a reader: the activity that naturally produces exercise-linked lipids and activates AMPK, and the plate that keeps the metabolic load low. The honest line is that the biology is interesting and the actionable version is already in the Recommended column plus movement.
The practical takeaway
For someone with fatty liver, the lipophagy study is context, not a prescription. The liver has its own fat-clearing pathway, exercise and the food pattern both support it, and no mouse-study molecule changes that. The database covers the plate; the routine covers the movement; the mechanism is the explanation in between.